Heme oxygenase-1-mediated neuroprotection in subarachnoid hemorrhage via intracerebroventricular deferoxamine

Table 2 Wild-type experimental mouse groups

Mouse group	Abbreviation	Explanation
WT SAH sham + IP NS + ICV NS	SAH sham + vehicle	Mice received subarachnoid hemorrhage (SAH), sham surgical procedure, daily intraperoteneal (IP) injections of normal saline (NS) starting on post-operative day (POD) 1 and ending on POD7, and a one-time intracerebroventricular (ICV) injection of NS on POD1.
WT SAH + IP NS + ICV NS	SAH + vehicle	Mice received SAH surgical procedure, daily IP injections of NS starting on POD1 and ending on POD7, and a one-time ICV injection of NS on POD1.
WT SAH + IP DFX + ICV NS	SAH + IP DFX	Mice received SAH surgical procedure, daily IP injections of deferoxamine (DFX) starting on POD1 and ending on POD7, and a one-time ICV injection of NS on POD1.
WT SAH + IP NS + ICV DFX	SAH + ICV DFX	Mice received SAH surgical procedure, daily IP injections of NS starting on POD1 and ending on POD7, and a one-time ICV injection of DFX on POD1.

Wild-type (WT) mice were randomly assigned between the four treatment groups listed in the table. Each mouse was exposed to all surgical procedures and injections as specified in the explanation. The abbreviation listed in the table was used throughout the results including figures and figure legends for simplicity.

ISSN: 1742-2094